A BiTE idea: engineered antibodies to attack tumors

In 10 seconds? Bi-specific T cell engagers (BiTEs) are an emerging cancer treatment strategy that work both to activate anti-cancer T cells and pull them in to kill tumors.

Wow, that sounds high-tech! And it is. BiTEs are essentially super mutant antibodies. We’ve talked a lot about other types of antibody-based cancer treatments like immune checkpoint therapies, but BiTEs take the engineering to the next level.